← Japan catalog ← 4543 Manual 4578 → ← 4523 Pharmaceuticals 4578 →
4568 · Daiichi Sankyo
The numbers below are read directly from Daiichi Sankyo’s EDINET filing, in yen. The Japanese-language narrative is not machine-read; the short business note that follows is written and reviewed by hand, grounded in the filing and the company’s established facts. Find it on EDINET (code 4568) →
The business in brief
- What it is
- Daiichi Sankyo is a Japanese pharmaceutical company. It discovers, develops, makes, and sells prescription medicines, selling to the doctors and hospitals that prescribe them and to the governments and insurers that mostly foot the bill. Making the pill costs little; the money rides on owning patented drugs that rivals are not permitted to copy.
- What moves the needle
- A drug under patent is a monopoly the law grants and the law later takes back, so the whole game is whether the pipeline keeps replacing what expires. Watch the gap between the cost of making a pill and the cost of finding the next one: the gross margin is wide because manufacturing is cheap, but research and the sales force eat into it, and the test is whether that outlay earns its keep or merely feeds itself. When a key patent lapses, generics turn yesterday's franchise into a commodity, so whether earnings lean on a handful of big drugs is the danger that scales with success. The figures for margins, returns, and the balance sheet are in the record below.
Written and reviewed by hand, grounded in the filing and the company’s established facts.
The record
What the business has done across the cycle, read straight from the EDINET filing: the multi-year record, and the walk from reported profit to the cash an owner could take out.
The record, 2017–2026
realized figures from each filing · older years to the left| 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | 2026’26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| ¥955.1B | ¥960.2B | ¥929.7B | ¥981.8B | ¥962.5B | ¥1.04T | ¥1.28T | ¥1.60T | ¥1.89T | ¥2.12T | RevenueRevenue |
| — | — | — | 65% | 65% | — | — | — | 78% | 68% | Gross marginGross mgn |
| — | — | — | 31% | 35% | — | — | — | 39% | 37% | SG&A / revenueSG&A/rev |
| — | — | — | 22% | 24% | — | — | — | 24% | 21% | R&D / revenueR&D/rev |
| ¥18.5B | ¥76.3B | ¥83.7B | ¥138.8B | ¥63.8B | ¥73.0B | ¥120.6B | ¥211.6B | ¥331.9B | ¥229.1B | Operating incomeOp. inc. |
| 1.9% | 7.9% | 9.0% | 14.1% | 6.6% | 7.0% | 9.4% | 13.2% | 17.6% | 10.8% | Operating marginOp. mgn |
| ¥53.5B | ¥60.3B | ¥93.4B | ¥129.1B | ¥76.0B | ¥67.0B | ¥109.2B | ¥200.7B | ¥295.8B | ¥259.9B | Net incomeNet inc. |
| Cash flow & returns | ||||||||||
| ¥136.2B | ¥108.4B | ¥92.0B | ¥196.6B | ¥192.2B | ¥139.2B | ¥114.5B | ¥599.3B | ¥53.8B | ¥77.7B | Operating cash flowOp. cash |
| — | ¥46.7B | ¥46.2B | ¥52.6B | ¥57.4B | ¥58.2B | ¥67.8B | ¥59.6B | ¥68.6B | ¥77.5B | DepreciationDeprec. |
| ¥82.8B | ¥1.5B | (¥47.5B) | ¥14.9B | ¥58.9B | ¥14.0B | (¥62.5B) | ¥338.9B | (¥310.6B) | (¥259.7B) | Working capital & otherWC & other |
| — | ¥23.4B | ¥36.1B | ¥31.9B | ¥31.2B | ¥62.7B | ¥60.7B | ¥88.3B | ¥116.3B | ¥128.4B | CapexCapex |
| — | 2.4% | 3.9% | 3.3% | 3.2% | 6.0% | 4.8% | 5.5% | 6.2% | 6.0% | Capex / revenueCapex/rev |
| — | ¥85.0B | ¥55.9B | ¥164.7B | ¥161.0B | ¥76.5B | ¥53.8B | ¥539.6B | (¥14.8B) | ¥195M | Owner earningsOwner earn. |
| — | 8.9% | 6.0% | 16.8% | 16.7% | 7.3% | 4.2% | 33.7% | −0.8% | 0.0% | Owner earnings marginOE mgn |
| — | ¥85.0B | ¥55.9B | ¥164.7B | ¥161.0B | ¥76.5B | ¥53.8B | ¥510.9B | (¥62.4B) | (¥50.7B) | Free cash flowFCF |
| — | 8.9% | 6.0% | 16.8% | 16.7% | 7.3% | 4.2% | 31.9% | −3.3% | −2.4% | Free cash flow marginFCF mgn |
| ¥43.9B | ¥46.4B | ¥45.3B | ¥45.4B | ¥48.9B | ¥51.7B | ¥54.6B | ¥67.1B | ¥114.3B | ¥128.4B | Dividends paidDiv. paid |
| ¥50.0B | ¥50.1B | ¥45M | ¥85M | ¥100.2B | ¥15M | ¥24M | ¥25M | ¥246.1B | ¥150.5B | BuybacksBuybacks |
| 2% | 6% | 5% | 10% | 5% | 7% | 8% | 15% | 24% | 12% | ROICROIC |
| 5% | 5% | 7% | 10% | 6% | 5% | 8% | 12% | 18% | 16% | Return on equityROE |
| 1% | 1% | 4% | 6% | 2% | 1% | 4% | 8% | 11% | 8% | Retained to equityRetained/eq |
| Balance sheet | ||||||||||
| ¥506.8B | ¥357.7B | ¥243.2B | ¥534.2B | ¥570.5B | ¥662.5B | ¥441.9B | ¥647.2B | ¥659.8B | ¥479.7B | Cash & investmentsCash+inv |
| ¥183.9B | ¥231.5B | ¥419.6B | ¥309.4B | ¥232.0B | ¥266.7B | ¥349.1B | ¥454.2B | ¥619.1B | ¥741.1B | ReceivablesReceiv. |
| ¥61.4B | ¥66.4B | ¥73.2B | ¥64.9B | ¥76.3B | ¥66.4B | ¥83.7B | ¥88.4B | ¥49.6B | ¥57.0B | InventoryInvent. |
| — | ¥226.2B | ¥312.7B | ¥270.9B | ¥297.5B | ¥324.8B | ¥395.2B | ¥557.1B | ¥580.0B | ¥596.9B | Accounts payablePayables |
| ¥245.3B | ¥71.8B | ¥180.1B | ¥103.4B | ¥10.9B | ¥8.3B | ¥37.7B | (¥14.5B) | ¥88.7B | ¥201.3B | Operating working capitalOper. WC |
| ¥847.1B | ¥1.20T | ¥1.39T | ¥1.38T | ¥1.27T | ¥1.35T | ¥1.50T | ¥2.17T | ¥1.91T | ¥2.14T | Current assetsCur. assets |
| ¥277.0B | ¥277.7B | ¥293.5B | ¥314.7B | ¥292.6B | ¥334.7B | ¥455.1B | ¥510.1B | ¥590.6B | ¥735.5B | Current liabilitiesCur. liab. |
| 3.1× | 4.3× | 4.7× | 4.4× | 4.3× | 4.0× | 3.3× | 4.3× | 3.2× | 2.9× | Current ratioCurr. ratio |
| — | ¥75.5B | ¥77.9B | ¥76.8B | ¥77.7B | ¥83.6B | ¥98.3B | ¥108.5B | ¥108.4B | ¥97.4B | GoodwillGoodwill |
| ¥1.91T | ¥1.90T | ¥2.09T | ¥2.11T | ¥2.09T | ¥2.22T | ¥2.51T | ¥3.46T | ¥3.46T | ¥4.01T | Total assetsAssets |
| ¥282.5B | ¥280.6B | ¥260.6B | ¥224.2B | ¥183.8B | ¥163.5B | ¥143.1B | ¥101.7B | ¥101.3B | ¥300.5B | Total debtDebt |
| (¥224.2B) | (¥77.1B) | ¥17.4B | (¥310.0B) | (¥386.7B) | (¥499.0B) | (¥298.8B) | (¥545.5B) | (¥558.5B) | (¥179.2B) | Net debt / (cash)Net debt |
| 35.1× | 18.1× | 14.2× | 17.8× | 23.2× | 12.7× | 14.2× | 35.1× | 28.0× | 28.7× | Interest coverageInt. cov. |
| ¥1.18T | ¥1.13T | ¥1.25T | ¥1.31T | ¥1.27T | ¥1.35T | ¥1.45T | ¥1.69T | ¥1.62T | ¥1.66T | Shareholders’ equityEquity |
| Per share | ||||||||||
| 2.13B | 2.13B | 2.13B | 2.13B | 2.13B | 1.95B | 1.95B | 1.95B | 1.91B | 1.89B | Shares out (diluted)Shares |
| ¥449.04 | ¥451.42 | ¥437.10 | ¥461.58 | ¥452.52 | ¥536.66 | ¥656.63 | ¥822.63 | ¥988.44 | ¥1120.72 | Revenue / shareRev/sh |
| ¥25.14 | ¥28.34 | ¥43.92 | ¥60.68 | ¥35.71 | ¥34.40 | ¥56.08 | ¥103.10 | ¥154.98 | ¥137.18 | EPS (diluted)EPS |
| — | ¥39.98 | ¥26.29 | ¥77.42 | ¥75.67 | ¥39.29 | ¥27.61 | ¥277.15 | ¥-7.76 | ¥0.10 | Owner earnings / shareOE/sh |
| — | ¥39.98 | ¥26.29 | ¥77.42 | ¥75.67 | ¥39.29 | ¥27.61 | ¥262.42 | ¥-32.71 | ¥-26.77 | Free cash flow / shareFCF/sh |
| ¥20.63 | ¥21.82 | ¥21.32 | ¥21.32 | ¥23.01 | ¥26.57 | ¥28.05 | ¥34.45 | ¥59.90 | ¥67.80 | Dividends / shareDiv/sh |
| — | ¥11.00 | ¥16.98 | ¥15.01 | ¥14.69 | ¥32.22 | ¥31.20 | ¥45.36 | ¥60.92 | ¥67.76 | Cap. spending / shareCapex/sh |
| ¥552.83 | ¥532.66 | ¥587.50 | ¥613.91 | ¥598.04 | ¥693.81 | ¥742.59 | ¥867.05 | ¥850.70 | ¥878.50 | Book value / shareBVPS |
Share counts before 2021 are restated ×3 for a stock split, so per-share figures sit on one basis.
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | +10.7%/yr | +19.9%/yr |
| Owner earnings / share | −52.5%/yr (8-yr) | −73.3%/yr |
| EPS | +20.8%/yr | +30.9%/yr |
| Dividends / share | +14.1%/yr | +24.1%/yr |
| Capital spending / share | +25.5%/yr (8-yr) | +35.8%/yr |
| Book value / share | +5.3%/yr | +8.0%/yr |
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2026 the business earned ¥195M of owner earnings, the operating cash left after the ¥77.5B it takes just to hold its position. It put ¥50.9B more into growth; free cash flow, after that spending, was (¥50.7B).
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Reported net income | ¥259.9B | ¥295.8B | ¥200.7B | ¥109.2B | ¥67.0B |
| Depreciation & amortizationnon-cash charge added back | +¥77.5B | +¥68.6B | +¥59.6B | +¥67.8B | +¥58.2B |
| Working capital & othertiming of cash in and out, other non-cash items | −¥259.7B | −¥310.6B | +¥338.9B | −¥62.5B | +¥14.0B |
| Cash from operations | ¥77.7B | ¥53.8B | ¥599.3B | ¥114.5B | ¥139.2B |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −¥77.5B | −¥68.6B | −¥59.6B | −¥60.7B | −¥62.7B |
| Owner earnings | ¥195M | (¥14.8B) | ¥539.6B | ¥53.8B | ¥76.5B |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −¥50.9B | −¥47.6B | −¥28.7B | — | — |
| Free cash flow | (¥50.7B) | (¥62.4B) | ¥510.9B | ¥53.8B | ¥76.5B |
| Owner-earnings marginowner earnings ÷ revenue | 0% | -1% | 34% | 4% | 7% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about ¥77.5B, roughly its depreciation, the rate its assets wear out). The other ¥50.9B of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows.
Much of fiscal 2026's profit didn't arrive as operating cash; it sits in “working capital & other” above. That can be a real inventory or timing swing, or profit that doesn't run through operating cash at all: a heavy tax year, equity-method earnings, or investment income booked through investing. For a year like this, owner earnings understates the cash earned; the full cash-flow statement carries the rest.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, and stewardship. The same checks the US pages run, in yen.
Owner’s Scorecard
Will it survive?
- Can it pay its interest? 28.7×ComfortableOperating income ¥229.1B ÷ interest expense ¥8.0B
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- How heavy is the debt, net of cash? +¥179.2BNet cashCash ¥449.8B + ST investments ¥29.9B − debt ¥300.5B
What this means
Cash and short-term investments exceed every dollar of debt by ¥179.2B, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Negative, funded by othersDSO 127 + DIO 31 − DPO 326 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. A negative cycle is a quiet moat: suppliers and customers fund the operation (Buffett's “float”), the company grows on other people's money.
Is it a good business?
- Below average through the cycle10-yr median, range 2%–24%; 12% latest = NOPAT ¥181.0B ÷ invested capital ¥1.51TIndustry peers: median 21%
What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 12% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
- Solid through the cycle9-yr median margin, range -1%–34%; latest ¥195M = operating cash ¥77.7B − maintenance capex ¥77.5BIndustry peers: median 36%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 0% of revenue this year, a 7% median across 9 years. It chose to put ¥50.9B more into growth, so free cash flow this year was (¥50.7B) — the gap is investment, not weakness.
- Thinly cash-backedCash from ops ¥77.7B ÷ net income ¥259.9B
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- Where do the earnings go? 143019%Returned more than it generatedDividends + buybacks ¥278.9B ÷ Owner Earnings ¥195M
What this means
The company returned more than it generated: against ¥195M of Owner Earnings, ¥278.9B (143019%) went back to shareholders, ¥128.4B dividends, ¥150.5B buybacks — the excess came from the balance sheet or borrowing, not the year's operations. Sustained, that pattern draws down cash or adds debt; the net-debt line above shows where it stands.
- Investing or harvesting? 1.66×ExpandingCapex ¥128.4B ÷ depreciation ¥77.5B
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
Durability & moat, 2017–2026
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 10 of 10
What this means
Never lost money over the record, the earnings stability Graham insisted on.
- Return on capital ≥ 15% 1 of 10 yrs
What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
- Operating margin 6% → 14% (3-yr avg ends)
What this means
Through the cycle the operating margin widened — about 6% early to 14% lately, median 9% — pricing power intact or improving.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Worst year 2017 · 1.9% op. margin
What this means
Stayed profitable even in its hardest year, the resilience that survives recessions.
- Dividend record rising
What this means
Paid and raised the dividend across the record, the continuity Graham prized.
All figures as filed; the source filing is linked above.
How the cash was used, 2018–2026
Over the record, the business generated ¥1.57T of operating cash; how management split it reads as a cash returner, paying most of what it earns straight back to owners.
- Reinvested¥579.1B · 37%
- Dividends¥602.2B · 38%
- Buybacks¥547.0B · 35%
- Returned to owners¥1.15T
102% of the owner earnings the business produced over the span, ¥602.2B as dividends and ¥547.0B as buybacks.
- Source of funding−¥154.6B
Reinvestment and shareholder returns ran ¥154.6B beyond the operating cash the business generated, so the gap was financed off the balance sheet.
- Average price paid for buybacks—
Buybacks ran ¥547.0B over the span, but the filings don't tag the share count needed to deduce the average price paid.
- Net change in share count−10.9%
The diluted count fell from 2127M to 1894M, so the buybacks outran the stock issued to staff.
- Dividend record¥67.80/sh
Paid in 9 of the years on record, the per-share dividend growing about 15% a year. It was never cut over the span.
- Return on what it retained51%
Of the earnings it kept rather than paid out (¥142.0B over the span), annual owner earnings (first three years vs last three) grew ¥73.1B, so each retained ¥1 added about 0.51 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Inverting the record
Invert: instead of why Daiichi Sankyo is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2017–2026.
1 of the 5 tests turned up something to look into; the other 4 came back clean.
- Look hereDid receivables and inventory outpace sales?26% → 38% of sales
Receivables and inventory grew from ¥245.3B to ¥798.2B while revenue grew 122%: working capital is climbing faster than sales (26% of revenue then, 38% now). That can mean customers paying slower, stock building up, or revenue pulled forward. The filing's cash-flow and receivables notes say which.
- Is it less profitable than it was?
- Did the share count rise anyway?
- Did debt outgrow the business?
- Did reported profit become cash?
Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.
The price
What a price would have to assume, set against the record above.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Daiichi Sankyo has delivered.
Daiichi Sankyo’s latest year shows negative owner earnings, the mark of a build-out: total capital spending outruns the cash the business throws off today. So the tool opens on the steady-state base (maintenance capex in place of the build-out spend), the cash it would earn at rest; clear the toggle below to read the latest year exactly as reported.
Through the cycle, Daiichi Sankyo earns about ¥155.4B on its 7.3% median owner-earnings margin. This year’s 0.0% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Free cash flow (¥50.7B) on 1894M diluted shares; net cash ¥179.2B. The base opens on the steady-state figure (the latest year is negative on total capex mid-build-out); clear Steady-state to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex (¥128.4B) runs well above depreciation (¥77.5B), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about ¥195M, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Figures from EDINET, the Financial Services Agency’s disclosure system, the same kind of filing the US pages draw from EDGAR. A separate pool: these names never pass through the US industry classifier.
Manual order: ← 4543 its page in the Manual 4578 →
Industry order: ← 4523 the Pharmaceuticals chapter 4578 →